Hacettepe University, Faculty of Medicine, Department of Pediatrics, Division of Social Pediatrics, Ankara, Turkey.
Sivas Cumhuriyet University, Faculty of Medicine, Department of Pediatrics, Sivas, Turkey.
Arch Pediatr. 2022 Nov;29(8):594-598. doi: 10.1016/j.arcped.2022.06.005. Epub 2022 Sep 25.
Vaccine hesitancy is a growing problem globally. This study aimed to detect the rates of vaccine refusal (VR) during childhood in each province and region of Turkey from 2016 to 2017 and to evaluate the experiences of Expanded Programme on Immunization (EPI) managers regarding childhood VR and opinions to solve and reduce vaccine hesitancy in Turkey.
VR was defined as the refusal to vaccinate for at least one vaccine in children aged 0-23 months. In this descriptive study, information on notified VR cases and recommended solutions from every province in Turkey was accessed by the local EPI manager for the period 2016-2017. The VR rates were calculated.
From 80 provinces, 8977 VR cases were detected in 2016 (VR rate 3.5‰) and 14,779 cases in 2017 (VR rate 5.9‰; p<0.001). One quarter of Family Health Units reported at least one case of VR. The highest VR rate in children aged under 2 years was in East Marmara (8.4‰) in 2016, and the West Anatolia Region (10.9‰) and East Marmara region (10.9‰) in 2017. Concerns about the vaccine content, harmfulness, and fears about adverse effects were the most common reasons underlying VR. Educating healthcare workers about vaccines and interpersonal communication skills, increasing patient information with informative brochures, and preventing anti-vaccination publications in the media were the most frequent recommendations to solve VR.
In Turkey, VR cases continue to increase. Correct and adequate information, effective communication, and trust between healthcare workers and parents can help reduce VR.
疫苗犹豫是一个全球性的问题。本研究旨在检测 2016 年至 2017 年期间土耳其每个省和地区的儿童疫苗拒绝率(VR),并评估扩大免疫规划(EPI)管理者在土耳其儿童 VR 方面的经验以及解决和减少疫苗犹豫的意见。
VR 被定义为拒绝为 0-23 个月大的儿童接种至少一种疫苗。在这项描述性研究中,通过当地 EPI 管理者获取了土耳其每个省在 2016-2017 年期间报告的 VR 病例数和建议的解决方案。计算了 VR 率。
从 80 个省中,2016 年检测到 8977 例 VR 病例(VR 率 3.5‰),2017 年检测到 14779 例 VR 病例(VR 率 5.9‰;p<0.001)。四分之一的家庭健康单位报告了至少一例 VR 病例。2016 年,东马尔马拉地区(8.4‰)2 岁以下儿童的 VR 率最高,2017 年,西安纳托利亚地区(10.9‰)和东马尔马拉地区(10.9‰)的 VR 率最高。对疫苗内容、危害性的担忧以及对不良反应的恐惧是 VR 最常见的原因。向医疗保健工作者提供有关疫苗的教育和人际沟通技巧、使用信息丰富的小册子增加患者信息、以及防止媒体发布反疫苗出版物是解决 VR 最常见的建议。
在土耳其,VR 病例继续增加。正确和充分的信息、有效的沟通以及医疗保健工作者和家长之间的信任可以帮助减少 VR。